Palvella Therapeutics, Inc.
PVLA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$17,434 | $18,691 | -$27,552 | -$45,738 |
| Dep. & Amort. | $0 | $0 | $0 | $2,368 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $830 | $603 | $427 | $0 |
| Change in WC | -$193 | -$3,149 | $1,621 | $30,525 |
| Other Non-Cash | $5,957 | -$29,848 | $10,664 | $5,185 |
| Operating Cash Flow | -$10,840 | -$13,703 | -$14,840 | -$7,660 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | -$949 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | -$949 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $78,434 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $59,127 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $8,655 | $5,000 | $9,566 | $0 |
| Financing Cash Flow | $87,089 | $5,000 | $9,566 | $59,127 |
| Forex Effect | $3 | $0 | $0 | -$3,190 |
| Net Chg. in Cash | $76,252 | -$8,703 | -$5,274 | $47,328 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $7,350 | $16,053 | $21,327 | $70,436 |
| End Cash | $83,602 | $7,350 | $16,053 | $117,764 |
| Free Cash Flow | -$10,840 | -$13,703 | -$14,840 | -$8,609 |